Indian scientists flag coronavirus mutations that could ‘evade immune response’

Published May 2, 2021
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters
People get their names registered after receiving a dose of Covishield, a Covid-19 vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1. — Reuters

A forum of scientific advisers set up by the Indian government has told authorities about minor mutations in some samples of the coronavirus that could “possibly evade immune response” and require more study, a leader of the forum has told Reuters.

However, the advisers said while they were flagging the mutations, there was no reason currently to believe they were expanding or could be dangerous.

Scientists are studying what led to the current surge in cases in India and particularly whether a variant first detected in the country, called B.1.617, is to blame. The World Health Organisation (WHO) has not declared the Indian variant a “variant of concern,” as it has done for variants first detected in Britain, Brazil and South Africa. But the WHO said on April 27 that its early modelling, based on genome sequencing, suggested that B.1.617 had a higher growth rate than other variants circulating in India.

The forum of advisers, known as the Indian SARS-CoV-2 Genetics Consortium, or INSACOG, has now found more mutations in the coronavirus that it thinks need to be tracked closely.

"We are seeing some mutation coming up in some samples that could possibly evade immune responses," said Shahid Jameel, chair of the scientific advisory group of INSACOG and a top Indian virologist. He did not say if the mutations have been seen in the Indian variant or any other strain.

"Unless you culture those viruses and test them in the lab, you can't say for sure. At this point, there is no reason to believe that they are expanding or if they can be dangerous, but we flagged it so that we keep our eye on the ball," he said.

INSACOG brings together 10 national research laboratories.

India reported more than 400,000 new Covid-19 cases for the first time on Saturday. The rampaging infections have collapsed its health system in places including capital New Delhi, with shortages of medical oxygen and hospital beds.

Opinion

Israeli flashpoint
Updated 12 May 2021

Israeli flashpoint

There are persistent reports from the US suggesting that the mood over unquestioning backing for Israel is shifting.
Blaming envoys for the mess
Updated 12 May 2021

Blaming envoys for the mess

The prime minister appeared to be using his container approach in the realm of foreign policy.
No entry, no Eid
12 May 2021

No entry, no Eid

On this Eid, amid this mess, many chairs at muted celebratory meals will remain empty.
Election night confusion
Updated 11 May 2021

Election night confusion

Poll manipulation in Pakistan occurs in the run-up to elections and on election day itself.

Editorial

PM’s Saudi visit
Updated 12 May 2021

PM’s Saudi visit

It is very important that Pakistan take no step, or agree to any demand, that can have an adverse effect on national sovereignty.
12 May 2021

A new intifada?

THE situation in the occupied territories over the past few days has been incendiary, with tensions boiling over as...
Updated 12 May 2021

SOP violations

ON Monday, Sindh Police officials were given a well-deserved slap on the wrist by a judicial magistrate in Karachi...
11 May 2021

Kabul massacre

AFGHANISTAN is a land that has seen plenty of massacres during decades of unrest. However, despite this almost...
Divisive move
Updated 11 May 2021

Divisive move

The whole point of these reforms is to ensure that all major political stakeholders are on board, and that there is a consensus.
11 May 2021

Bank loan concerns

THE combined gross non-performing loan portfolio of the country’s banks and DFIs increased marginally by 2.6pc or...